Search
for

    Sort by

    Research

    90-120 / 1000+ results
      Acquired Scalp Alopecia: A Review

      research Acquired scalp alopecia. Part I: A review

      44 citations , November 1998 in “Australasian Journal of Dermatology”
      Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.
      Current Evaluation of Amenorrhea

      research Current evaluation of amenorrhea

      30 citations , July 2004 in “Fertility and Sterility”
      Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.
      Current Evaluation of Amenorrhea

      research Current evaluation of amenorrhea

      21 citations , September 2004 in “Fertility and Sterility”
      Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.
      Endocrinological Assessment in Transgender Individuals

      research The Transgender: Endocrinological Assessment

      October 2022 in “Springer eBooks”
      The document concludes that personalized hormonal treatments are important for transgender individuals and more research is needed for non-binary treatments.

      research Arzneimitteltherapie der Alopezien

      September 2015 in “Der Internist”
      Finasteride and minoxidil are effective for hair loss, with potential side effects, and JAK inhibitors show promise for alopecia areata.
      Bioengineering the Hair Follicle

      research Bioengineering the Hair Follicle

      26 citations , January 2007 in “Organogenesis”
      Bioengineering can potentially treat hair loss by regenerating hair follicles and cloning hair, but the process is complex and needs more research.
      Finasteride-Induced Gynecomastia: Case Reports and Review

      research Finasteride-induced gynecomastia

      8 citations , January 2009 in “Indian Journal of Dermatology, Venereology and Leprology”
      Finasteride can cause rare breast growth side effect, with varying recovery after stopping.
      Endocrinology Overview: Male Reproductive Endocrinology and HPT Axis

      research Endocrinology Overview RSS

      January 2018 in “Elsevier eBooks”
      The document explains how male reproductive hormones work and affect the body.
      LOP14

      research LOP14

      July 2014 in “Plastic and Reconstructive Surgery”
      The document concludes that rib-sparing techniques in breast reconstruction have limited benefits, sentinel lymph node biopsy is needed for desmoplastic melanoma, certain hair preservation methods improve graft survival, partial turbinectomy effectively reduces nasal obstruction, nipple shields with irrigation may reduce capsular contracture, and thicker malignant melanomas have a higher risk of non-skin cancers.
      LOP14

      research LOP14

      July 2014 in “Plastic and Reconstructive Surgery”
      The document concludes that rib-sparing techniques in breast reconstruction have limited benefits, sentinel lymph node biopsy is needed for desmoplastic melanoma, certain hair preservation methods improve graft survival, partial turbinectomy effectively reduces nasal obstruction, nipple shields with irrigation may reduce capsular contracture, and thicker malignant melanomas have a higher risk of non-skin cancers.
      Penis Endocrinology

      research Penis Endocrinology

      November 2017
      Hormones, especially testosterone and DHT, are key for penis development and function, and testosterone therapy may help with erectile dysfunction in those with low levels.
      Clinical Case Notes: Tamoxifen Optic Neuropathy

      research Clinical Case Notes. Tamoxifen optic neuropathy

      23 citations , February 2004 in “Clinical and Experimental Ophthalmology”
      A boy with chromosome 13q deletion syndrome developed eye cancer, a woman with breast cancer lost vision due to a rare side-effect of her treatment, a man's vision worsened after using a hair loss drug, and two rare disorders were discussed. Optical Coherence Tomography is useful for diagnosing and monitoring these conditions.
      Men's Health

      research Men??s Health

      February 1999 in “Drugs in R & D”
      The document concludes that various drugs for men's health issues are in development, with treatments for sexual dysfunction and prostate conditions being the most advanced.
      Clinical Case Notes: Lipoid Proteinosis - A Rare Disorder with Pathognomonic Lid Lesions

      research Clinical Case Notes. Lipoid proteinosis: a rare disorder with pathognomonic lid lesions

      13 citations , February 2004 in “Clinical and Experimental Ophthalmology”
      A baby boy with 13q deletion syndrome had eye cancer, a woman's vision improved after stopping a breast cancer drug, a man developed cataracts from using Propecia, and a rare skin disorder called Lipoid Proteinosis was discussed. Also, a tool called OCT is useful for diagnosing macular diseases.
      Acne

      research ACNE

      58 citations , January 1997 in “Dermatologic Clinics”
      Acne significantly affects mental health and quality of life, with research suggesting hormonal and genetic factors in its development and emphasizing early treatment to prevent scarring.
      Steroid Sulfatase Inhibitors: Therapeutic Applications and Development

      research Steroid sulfatase inhibitors

      25 citations , May 2003 in “Expert Opinion on Therapeutic Patents”
      Steroid Sulfatase inhibitors show promise in treating hormone-dependent disorders like cancers, hair loss, and acne, with 667COUMATE being a potential candidate for breast cancer treatment trials.
      News on PCOS

      research Actualités du SOPK

      December 2006 in “Annales D Endocrinologie”
      Estrogen-progestin contraception lowers ovarian, endometrial, and colon cancer risk but may raise breast and cervical cancer risk, helps with menstrual and acne issues, and new methods are as effective as pills. Metformin helps overweight women with PCOS and insulin resistance, and dopamine agonists treat prolactinomas.